Star Imaging And Path Lab Ltd vs Suven Life Sciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Star Imaging and Path Lab Ltd is ₹ 74.7 as of 23 Oct 15:30 . The P/E Ratio of Star Imaging and Path Lab Ltd changed from 4.2 on March 2026 to 4.2 on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Suven Life Sciences Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Star Imaging and Path Lab Ltd changed from ₹ 80.64 crore on March 2026 to ₹ 80.64 crore on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Suven Life Sciences Ltd changed from ₹ 896.07 crore on March 2021 to ₹ 3503 crore on March 2026 . This represents a CAGR of 25.51% over 6 years The revenue of Star Imaging and Path Lab Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Suven Life Sciences Ltd for the Jun '26 is ₹ 11.09 crore as compare to the Mar '26 revenue of ₹ 8.3 crore. This represent the growth of 33.61% The ebitda of Star Imaging and Path Lab Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Suven Life Sciences Ltd for the Jun '26 is ₹ -124 crore as compare to the Mar '26 ebitda of ₹ -43.86 crore. This represent the growth of 184.95% The net profit of Star Imaging and Path Lab Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Suven Life Sciences Ltd changed from ₹ -28.04 crore to ₹ -127 crore over 9 quarters. This represents a CAGR of 96.11% The Dividend Payout of Star Imaging and Path Lab Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Suven Life Sciences Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Star Imaging and Path Lab Ltd

Star Imaging and Path Lab Limited was originally incorporated as a private limited Company as 'Star Imaging & Path Lab Private Limited' dated May 31, 2004, issued by the Registrar of Companies, National Capital Territory of Delhi and Haryana.
Subsequently, it converted into a Public Company and the name of the Company was changed to 'Star Imaging and Path Lab Limited' on September 17, 2024 issued by Central Processing Centre. The Company started its journey from 1978 as proprietorship under the name of Janta X-Ray Clinic and were providing X-ray and basic pathology tests using manual methods.
Over the years, they have upgraded their services, equipment, and diagnostic technologies to incorporate latest advancements in medical science, ensuring the care and improved patient outcomes.
This vision led to establishment of Star Imaging & Path Lab Private Limited in 2004, as Private Limited entity, to offer pathology, radiology, Cardiology, and Neurology services under one roof.

About Suven Life Sciences Ltd

Suven Life Sciences Limited, formerly known as Suven Pharmaceuticals Limited was incorporated in March, 1989.
The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limited in September, 2003.
Promoted by Venkateswarlu Jasti, Company began its operations in 1989 as specialty chemicals provider. The Company is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders.
Suven has a wholly owned subsidiary, Suven Neurosciences, Inc., USA, focused on clinical development activities of Suven molecules from phase 2, Proof-of-Concept (POC) studies. The Company is in the business of Contract Research And Manufacturing Services (CRAMS), catering to the needs of global life science industry and fine chemical majors.

FAQs for the comparison of Star Imaging and Path Lab Ltd and Suven Life Sciences Ltd

Which company has a larger market capitalization, Star Imaging and Path Lab Ltd or Suven Life Sciences Ltd?

Market cap of Star Imaging and Path Lab Ltd is 130 Cr while Market cap of Suven Life Sciences Ltd is 7,397 Cr

What are the key factors driving the stock performance of Star Imaging and Path Lab Ltd and Suven Life Sciences Ltd?

The stock performance of Star Imaging and Path Lab Ltd and Suven Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Star Imaging and Path Lab Ltd and Suven Life Sciences Ltd?

As of October 24, 2026, the Star Imaging and Path Lab Ltd stock price is INR ₹74.7. On the other hand, Suven Life Sciences Ltd stock price is INR ₹261.8.

How do dividend payouts of Star Imaging and Path Lab Ltd and Suven Life Sciences Ltd compare?

To compare the dividend payouts of Star Imaging and Path Lab Ltd and Suven Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.